# Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)

> **NCT05587621** · NA · NOT_YET_RECRUITING · sponsor: **Jena University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- ST Elevation Myocardial Infarction
- Non-ST Elevation Myocardial Infarction
- LDL-cholesterol

## Interventions

- **DRUG:** statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran

## Key facts

- **NCT ID:** NCT05587621
- **Lead sponsor:** Jena University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05587621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05587621, "Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05587621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*